-+ 0.00%
-+ 0.00%
-+ 0.00%

ALVOTECH ANNOUNCES FDA ACCEPTANCE OF BIOLOGICS LICENSE APPLICATION FOR AVT16, A PROPOSED INTERCHANGEABLE BIOSIMILAR TO ENTYVIO®

Reuters·06/08/2026 08:00:00

Please log in to view news